Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
EMBO Molecular Medicine|May 10, 2024
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinomaMatilde Simoni, Chiara Menegazzi, Cristina Fracassi, et al.
Cancer Biology & Therapy|March 25, 2015
Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombusRaquibul Hannan, Vitaly Margulis, Stephen G Chun, et al.
Clinical Genitourinary Cancer|May 23, 2016
Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor CellularityQing Yuan, Payal Kapur, Yue Zhang, et al.
Cancer|January 3, 2014
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinomaRichard W Joseph, Payal Kapur, Daniel J Serie, et al.
Ebiomedicine|December 21, 2019
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive typeQi Cai, Alana Christie, Satwik Rajaram, et al.
Cancer Research|June 2, 2022
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep LearningPaul H Acosta, Vandana Panwar, Vipul Jarmale, et al.
Clinical Genitourinary Cancer|October 1, 2015
Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging AssessmentsYue Zhang, Payal Kapur, Qing Yuan, et al.
Journal for Immunotherapy of Cancer|November 3, 2020
Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinomaViral Patel, Roy Elias, Joseph Formella, et al.
European Urology Oncology|September 17, 2022
Predicting Oncologic Outcomes in Small Renal TumorsPayal Kapur, Hua Zhong, Ellen Araj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell CarcinomaJames Brugarolas, Gregory Obara, Kathryn E Beckermann, et al.
Pageof 18